Surrey Heartlands

Joint Formulary & PAD

Zanamivir - Influenza

You are here : Home > Formulary Search > Zanamivir - Influenza

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green
Formulations :
  • Inhalation
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
Restrictions / Comments :
Important

recommended for  treatment of influenza in adults and children meeting the criteria set out in NICE TA 168 and for prophylaxis of influenza in adults and children meeting the criteria set out in NICE TA 158

 

Status 2

Red
Formulations :
  • Infusion
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
R
Restrictions / Comments :
Important

Restricted antimicrobial - to be used on advice of microbiologist

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Zanamivir
Indication :
Influenza
Group Name :
Keywords :
prophylaxis
Brand Names Include :
Relenza
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Traffic Light Entries :
2

Other Indications

Below are listed other indications that Zanamivir is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Influenza.

Committee Recommendations (1)

01 Jan 25 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.